(b)(6) study.It was reported that a stent fracture occurred.The subject was enrolled in the (b)(6) study on (b)(6) 2016 and the index procedure was performed on the same day.Target lesion #1 was located in the right leg distal superficial femoral artery (sfa) extending to ppa with 100% stenosis and was 150 mm long with a proximal reference vessel diameter of 5.00 mm and distal vessel diameter of 5.00 mm and was classified as tasc ii b lesion.Target lesion #1 was treated with pre-dilatation and placement of a 6.0 x 150 mm, 130cm eluvia drug-eluting vascular study stent.Following post-dilatation, residual stenosis was 10%.On (b)(6) 2016, the subject was discharged on dual antiplatelet therapy.On (b)(6) 2021, during 60 months follow up visit, diagnostic test of x-ray was performed, which was sent to core lab revealing stent fracture of grade ii - multiple tine fracture was noted.No adverse event associated with stent fracture was reported.
|